A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases

The development of broad-spectrum antivirals against human coronaviruses (HCoVs) is critical to combat the current coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants, as well as future outbreaks of emerging CoVs. We ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jie, Xu, Wei, Liu, Zezhong, Wang, Chao, Xia, Shuai, Lan, Qiaoshuai, Cai, Yanxing, Su, Shan, Pu, Jing, Xing, Lixiao, Xie, Youhua, Lu, Lu, Jiang, Shibo, Wang, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327648/
https://www.ncbi.nlm.nih.gov/pubmed/34367893
http://dx.doi.org/10.1016/j.apsb.2021.07.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327648/
https://www.ncbi.nlm.nih.gov/pubmed/34367893
http://dx.doi.org/10.1016/j.apsb.2021.07.026

Ejemplares similares